Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Oppenheimer analyst Jay Olson initiated coverage on BIOAGE Labs Inc (NASDAQ:BIOA) with an Outperform rating and announced a price target of $60. Bioage Labs shares closed at $21.56 on Tuesday. See how other analysts view this stock.
- B. Riley Securities analyst Drew Crum initiated coverage on Angel Studios Inc (NYSE:ANGX) with a Buy rating and announced a price target of $7. Angel Studios shares closed at $3.26 on Tuesday. See how other analysts view this stock.
- Stifel analyst Alex Thompson initiated coverage on Palisade Bio Inc (NASDAQ:PALI) with a Buy rating and announced a price target of $5. Palisade Bio shares closed at $1.79 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on Q32 Bio Inc (NASDAQ:QTTB) with a Buy rating and announced a price target of $13. Q32 Bio shares closed at $4.50 on Tuesday. See how other analysts view this stock.
- Stifel analyst Alex Thompson initiated coverage on Alumis Inc (NASDAQ:ALMS) with a Buy rating and announced a price target of $44. Alumis shares closed at $28.08 on Tuesday. See how other analysts view this stock.
Considering buying ALMS stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments